Kiniksa (NASDAQ: KNSA) CEO Sanj K. Patel exercises options, sells 48,565 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Kiniksa Pharmaceuticals International, plc Chairman and CEO Sanj K. Patel reported an exercise-and-sale transaction in Class A Ordinary Shares. He exercised share options to acquire 48,565 shares at $30.93 per share and then sold 48,565 shares in an open-market transaction at a weighted-average price of $54.02 per share.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan dated October 31, 2025. Following these direct transactions, his directly held Class A Ordinary Shares were reduced to zero, while separate indirect holdings remain in several family trusts.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 48,565 shares ($2,623,481)
Net Sell
6 txns
Insider
Patel Sanj K
Role
CHAIRMAN & CEO
Sold
48,565 shs ($2.62M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Share Option | 48,565 | $0.00 | -- |
| Exercise | Class A Ordinary Share | 48,565 | $30.93 | $1.50M |
| Sale | Class A Ordinary Share | 48,565 | $54.02 | $2.62M |
| holding | Class A Ordinary Share | -- | -- | -- |
| holding | Class A Ordinary Share | -- | -- | -- |
| holding | Class A Ordinary Share | -- | -- | -- |
Holdings After Transaction:
Share Option — 0 shares (Direct, null);
Class A Ordinary Share — 48,565 shares (Direct, null);
Class A Ordinary Share — 76,174 shares (Indirect, Held by The Patel Family Irrevocable Trust of 2025)
Footnotes (1)
- This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.155. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. The option is fully vested and exercisable.
Key Figures
Shares sold: 48,565 shares
Sale price: $54.02 per share
Option exercise price: $30.93 per share
+2 more
5 metrics
Shares sold
48,565 shares
Open-market sale of Class A Ordinary Shares on May 1, 2026
Sale price
$54.02 per share
Weighted-average sale price, trades between $54.00 and $54.155
Option exercise price
$30.93 per share
Exercise price for 48,565 share options converted into Class A Ordinary Shares
Options exercised
48,565 options
Share options exercised into Class A Ordinary Shares on May 1, 2026
Indirect trust holdings
51,794; 109,795; 76,174 shares
Class A Ordinary Shares held through family trusts as indirect ownership
Key Terms
Rule 10b5-1 plan, weighted average sales price, share option, exercise or conversion of derivative security, +1 more
5 terms
Rule 10b5-1 plan regulatory
"This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average sales price financial
"The price reported in this column reflects a weighted average sales price"
exercise or conversion of derivative security financial
"Transaction code description: Exercise or conversion of derivative security"
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
